Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sacerdote

Showing results (691-700 of 1,002) with videos related to

Pageof 101
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
Mitochondrial DNA Copy-Number Variation and Pancreatic Cancer Risk in the Prospective EPIC CohortManuel Gentiluomo, Verena A Katzke, Rudolf Kaaks, et al.
BMC Medicine|July 14, 2017
Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort studyAurora Perez-Cornago, Paul N Appleby, Tobias Pischon, et al.
Plos One|March 5, 2011
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Daniele Campa, Anika Hüsing, Angelika Stein, et al.
European Journal of Clinical Nutrition|November 6, 2009
Dietary intakes of retinol, beta-carotene, vitamin D and vitamin E in the European Prospective Investigation into Cancer and Nutrition cohortM Jenab, S Salvini, C H van Gils, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2017
Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC CohortDanja Sarink, Helena Schock, Theron Johnson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and NutritionNaomi E Allen, Timothy J Key, Paul N Appleby, et al.
British Journal of Cancer|May 14, 2009
Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and NutritionR C Travis, E A Spencer, N E Allen, et al.
International Journal of Cancer|January 30, 2018
Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancerJulia Butt, Mazda Jenab, Martina Willhauck-Fleckenstein, et al.
International Journal of Cancer|February 4, 2020
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC studyDelphine Casabonne, Yolanda Benavente, Julia Seifert, et al.
The American Journal of Clinical Nutrition|August 30, 2022
Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2)Marta Crous-Bou, Mengmeng Du, Marc J Gunter, et al.
Pageof 101

Showing results (691-700 of 1,002) with videos related to

Sort By:
Pageof 101
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
Mitochondrial DNA Copy-Number Variation and Pancreatic Cancer Risk in the Prospective EPIC CohortManuel Gentiluomo, Verena A Katzke, Rudolf Kaaks, et al.
BMC Medicine|July 14, 2017
Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort studyAurora Perez-Cornago, Paul N Appleby, Tobias Pischon, et al.
Plos One|March 5, 2011
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Daniele Campa, Anika Hüsing, Angelika Stein, et al.
European Journal of Clinical Nutrition|November 6, 2009
Dietary intakes of retinol, beta-carotene, vitamin D and vitamin E in the European Prospective Investigation into Cancer and Nutrition cohortM Jenab, S Salvini, C H van Gils, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2017
Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC CohortDanja Sarink, Helena Schock, Theron Johnson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and NutritionNaomi E Allen, Timothy J Key, Paul N Appleby, et al.
British Journal of Cancer|May 14, 2009
Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and NutritionR C Travis, E A Spencer, N E Allen, et al.
International Journal of Cancer|January 30, 2018
Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancerJulia Butt, Mazda Jenab, Martina Willhauck-Fleckenstein, et al.
International Journal of Cancer|February 4, 2020
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC studyDelphine Casabonne, Yolanda Benavente, Julia Seifert, et al.
The American Journal of Clinical Nutrition|August 30, 2022
Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2)Marta Crous-Bou, Mengmeng Du, Marc J Gunter, et al.
Pageof 101